Amneal Pharmaceuticals【AMRX】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

8.19

買値

8.19

売値

8.20

出来高

469,193

8.1801 日の範囲 8.38

5.01 52 週間の範囲 9.475

時価総額

2.538B

前日終値

8.31

始値

8.35

時刻

100

8.1916

(average)

最終取引時間

04:17:23

財務取引量

US$ 3,889,740

VWAP

8.2903

平均取引量 (3 か月)

1,123,422

発行済株式数

309,844,430

配当利回り

PER

-21.65

1 株当たり利益 (EPS)

-0.27

歳入

2.41B

純利益

-83.99M

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inha... Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.amneal.com

本社

Wilmington, Delaware, USA

設立

Amneal Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker AMRX. The last closing price for Amneal Pharmaceuticals was US$8.31. Over the last year, Amneal Pharmaceuticals shares have traded in a share price range of US$ 5.01 to US$ 9.475.

Amneal Pharmaceuticals currently has 309,844,430 shares in issue. The market capitalisation of Amneal Pharmaceuticals is US$2.57 billion. Amneal Pharmaceuticals has a price to earnings ratio (PE ratio) of -21.65.

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Amneal to Participate at Upcoming Investor Conferences

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, announced today that Chirag Patel, Co-Chief Executive Officer and President, and Tasos...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist

Potential first and only DHE autoinjector for tough-to-treat migraines and cluster headaches Exenatide approval highlights Amneal’s capabilities in developing GLP-1 injectables Amneal...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.17	2.11970074813	8.02	8.42	7.69	1190601	8.03660133	CS
4	0.5	6.50195058518	7.69	8.42	7.57	1059430	7.9142331	CS
12	-0.18	-2.15053763441	8.37	9.475	7.52	1123422	8.30923109	CS
26	0.67	8.90957446809	7.52	9.475	6.5	1175254	8.19485431	CS
52	2.89	54.5283018868	5.3	9.475	5.01	1317057	7.04849597	CS
156	2.31	39.2857142857	5.88	9.475	5.01	1328703	6.97558968	CS
260	2.31	39.2857142857	5.88	9.475	5.01	1328703	6.97558968	CS

AMRX - Frequently Asked Questions (FAQ)

What is the current Amneal Pharmaceuticals share price?

The current share price of Amneal Pharmaceuticals is US$ 8.19

How many Amneal Pharmaceuticals shares are in issue?

Amneal Pharmaceuticals has 309,844,430 shares in issue

What is the market cap of Amneal Pharmaceuticals?

The market capitalisation of Amneal Pharmaceuticals is USD 2.57B

What is the 1 year trading range for Amneal Pharmaceuticals share price?

Amneal Pharmaceuticals has traded in the range of US$ 5.01 to US$ 9.475 during the past year

What is the PE ratio of Amneal Pharmaceuticals?

The price to earnings ratio of Amneal Pharmaceuticals is -21.65

What is the cash to sales ratio of Amneal Pharmaceuticals?

The cash to sales ratio of Amneal Pharmaceuticals is 0.75

What is the reporting currency for Amneal Pharmaceuticals?

Amneal Pharmaceuticals reports financial results in USD

What is the latest annual turnover for Amneal Pharmaceuticals?

The latest annual turnover of Amneal Pharmaceuticals is USD 2.41B

What is the latest annual profit for Amneal Pharmaceuticals?

The latest annual profit of Amneal Pharmaceuticals is USD -83.99M

What is the registered address of Amneal Pharmaceuticals?

The registered address for Amneal Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Amneal Pharmaceuticals website address?

The website address for Amneal Pharmaceuticals is www.amneal.com

Which industry sector does Amneal Pharmaceuticals operate in?

Amneal Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
CRKNCrown Electrokinetics Corporation	US$ 0.1396 (75.16%)	536.22M
BTCTBTC Digital Ltd	US$ 7.944 (66.89%)	33.47M
BDMDBaird Medical Investment Holdings Ltd	US$ 8.9288 (64.74%)	17M
NUKKNukkleus Inc	US$ 32.10 (56.36%)	17.36M
GSITGSI Technology	US$ 4.0199 (46.18%)	83.21M
LGCBLinkage Global Inc	US$ 0.28 (-24.32%)	763.83k
PMAXPowell Max Ltd	US$ 0.6651 (-19.85%)	3.32M
BKYIBIO key International Inc	US$ 1.7182 (-18.57%)	811.29k
AENTAlliance Entertainment Holding Corporation	US$ 4.85 (-18.35%)	156.27k
BLRXBioLineRx Ltd	US$ 0.10 (-17.97%)	23.83M
CRKNCrown Electrokinetics Corporation	US$ 0.1396 (75.16%)	536.22M
GCTKGlucoTrack Inc	US$ 0.0877 (18.83%)	438.92M
RIMEAlgorhythm Holdings Inc	US$ 0.041 (-3.07%)	282.09M
TGLTreasure Global Inc	US$ 0.2743 (28.00%)	254.09M
NVDANVIDIA Corporation	US$ 137.88 (3.23%)	137.81M